EverSource Wealth Advisors’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127K Buy
1,833
+282
+18% +$18.6K ﹤0.01% 1254
2026
Q1
$107K Buy
1,551
+216
+16% +$16.9K ﹤0.01% 1392
2025
Q4
$118K Buy
1,335
+52
+4% +$4.43K ﹤0.01% 1229
2025
Q3
$107K Buy
1,283
+361
+39% +$31.4K ﹤0.01% 1246
2025
Q2
$86.2K Buy
922
+813
+746% +$77K ﹤0.01% 1287
2025
Q1
$11.5K Buy
109
+15
+16% +$1.55K ﹤0.01% 2031
2024
Q4
$9.09K Buy
94
+3
+3% +$299 ﹤0.01% 2047
2024
Q3
$8.99K Buy
91
+21
+30% +$1.92K ﹤0.01% 1928
2024
Q2
$5.97K Buy
70
+57
+438% +$4.48K ﹤0.01% 2151
2024
Q1
$963 Hold
13
﹤0.01% 2596
2023
Q4
$987 Sell
13
-36
-73% -$2.51K ﹤0.01% 2405
2023
Q3
$3.38K Sell
49
-33
-40% -$2.38K ﹤0.01% 1847
2023
Q2
$6.86K Hold
82
﹤0.01% 1600
2023
Q1
$6.06K Buy
82
+7
+9% +$491 ﹤0.01% 1571
2022
Q4
$5.3K Sell
75
-12
-14% -$801 ﹤0.01% 1575
2022
Q3
$5K Hold
87
﹤0.01% 1381
2022
Q2
$5K Buy
+87
New +$5.31K ﹤0.01% 1271

Other funds holding MMSI

EverSource Wealth Advisors's MMSI Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Merit Medical Systems (MMSI) stake by 18% in Q2 2026, buying an estimated $18.6K and bringing the position to 1,833 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

EverSource Wealth Advisors first reported a position in MMSI in Q2 2022 and has held it in 17 quarters since. 403 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • EverSource Wealth Advisors held 1,833 shares of Merit Medical Systems worth $127K as of Q2 2026.
  • EverSource Wealth Advisors bought 282 Merit Medical Systems shares in Q2 2026, an estimated $18.6K.
  • Merit Medical Systems made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1254 holding.
  • EverSource Wealth Advisors first reported a position in Merit Medical Systems in Q2 2022 and has held it in 17 quarters since.
  • 403 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.